CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients
Titel:
CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients
Auteur:
Vianello, C. Leoni, I. Galvani, G. Monti, E. Marinelli, S. Marisi, G. Gardini, A. Casadei Foschi, G.F. Giovannini, C. Ravaioli, M. Cescon, M. Vasuri, F. Negrini, M. Piscaglia, F. Stefanelli, C. Gramantieri, L. Fornari, F.